文献速递神经肿瘤

长链非编码RNA LINC01018通过直接靶向miRNA-182-5p抑制人胶质瘤细胞增殖与转移

Long non-coding RNA LINC01018 inhibits human glioma cell proliferation and metastasis by directly targeting miRNA-182-5p.
PubMed 文献 · J Neurooncol · 2022-09-12

研究检测了LINC01018与miR-182-5p在临床胶质瘤组织及细胞系中的表达,并通过CCK-8、Transwell、Western blotting、双荧光素酶报告、RIP及回复实验等体外实验探讨其功能与直接靶向关系;结果显示LINC01018在胶质瘤中显著下调,过表达可抑制增殖、迁移、侵袭并逆转EMT,miR-182-5p上调可逆转上述抑制作用。

要点

  • LINC01018在胶质瘤组织与细胞系中显著下调。
  • 过表达LINC01018可抑制胶质瘤细胞增殖、迁移、侵袭并逆转EMT过程。
  • LINC01018直接靶向miR-182-5p,miR-182-5p上调可逆转其抑制效应。

核心结论

  • LINC01018通过靶向miR-182-5p抑制人胶质瘤细胞增殖与转移,作者认为其应被视为该肿瘤的潜在治疗靶点。

研究设计与样本

  • 体外研究:采用qRT-PCR检测临床胶质瘤组织与细胞系中LINC01018及miR-182-5p的表达,用CCK-8与Transwell实验检测增殖、迁移和侵袭,用Western blotting检测EMT相关蛋白,用双荧光素酶报告实验、RNA免疫沉淀实验(RIP)及回复实验验证LINC01018与miR-182-5p的直接关系,并用生物信息学分析预测LINC01018/miR-182-5p轴的下游因子。

主要发现

  • LINC01018在胶质瘤组织和细胞系中显著下调。
  • 过表达LINC01018显著抑制胶质瘤细胞增殖、迁移和侵袭,并逆转EMT过程。
  • LINC01018直接靶向miR-182-5p,强制上调miR-182-5p可逆转LINC01018过表达对胶质瘤细胞增殖和转移能力的抑制作用。
  • 生物信息学分析显示LINC01018/miR-182-5p轴介导一组下游基因(ADRA2C、RAB6B、RAB27B、RAPGEF5、STEAP2、TAGLN3和UNC13C),这些基因可能是胶质瘤发生发展的潜在关键因子。

临床怎么用

  • 作者认为LINC01018应被视为胶质瘤的潜在治疗靶点,原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Accumulating evidence suggests that lncRNAs are potential biomarkers and key regulators of tumor development and progression. However, the precise function of most lncRNAs in glioma remains unknown. In this study, we explored the role of long intergenic non-protein coding RNA 1018 (LINC01018) in human glioma. METHODS: Expression levels of LINC01018 and miR-182-5p in clinical glioma tissues and cell lines were detected by quantitative real-time PCR (qRT-PCR). Cell proliferation, migration, and invasion were determined by Cell Counting Kit-8 (CCK-8) assay and Transwell assay. Epithelial-mesenchymal transition (EMT) related proteins were measured by Western blotting. Direct relationship between LINC01018 and miR-182-5p was tested by dual-luciferase reporter assay, RNA immunoprecipitation assay (RIP), and rescue assays. Lastly, bioinformatics analyses were conducted to predict the downstream factors of LINC01018/miR-182-5p axis in glioma. RESULTS: LINC01018 was significantly down-regulated in glioma tissues and cell lines. Overexpression of LINC01018 dramatically inhibited cell proliferation, migration, and invasion and reverse EMT process in glioma. LINC01018 directly target to miR-182-5p. Forced up-regulation of miR-182-5p reversed the inhibitory effects on proliferative and metastatic abilities of glioma cells with LINC01018 overexpression. Lastly, the bioinformatics analyses revealed that LINC01018/miR-182-5p axis mediated a cluster of downstream genes (ADRA2C, RAB6B, RAB27B, RAPGEF5, STEAP2, TAGLN3, and UNC13C), which were potential key factors in the development of glioma. CONCLUSION: LINC01018 inhibits cell proliferation and metastasis in human glioma by targeting miR-182-5p, and should be considered as a potential therapeutic target in this cancer.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Su H, Hailin Z, Dongdong L, et al. Long non-coding RNA LINC01018 inhibits human glioma cell proliferation and metastasis by directly targeting miRNA-182-5p. J Neurooncol. 2022. PMID: 36094613. doi:10.1007/s11060-022-04113-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。